Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Omeros Corporation seeks a remote Senior Manager, Patient Services & Advocacy to lead the development of reimbursement resources, patient access programs, and education for providers, patients, and caregivers. The role emphasizes strategic relationships with patient advocacy organizations and clinical societies to improve access and outcomes.
You will drive cross-functional initiatives across Marketing, Market Access, Medical Affairs, Regulatory, and Sales while traveling to meetings as needed;
Omeros is currently recruiting a remote Senior Manager, Patient Services & Advocacy. The role will focus on developing and managing patient access and reimbursement resources, education, and services for healthcare providers, provider offices, patients, and caregivers, while building strategic relationships with patient advocacy organizations and relevant clinical and professional societies.
The ideal candidate will be a high-energy, purpose-driven leader who is a strategic thinker, strong relationship-builder, and skilled operator with a passion for improving the patient access experience.
Omeros is an innovative biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for both large-market and orphan indications, with a focus on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead complement inhibitor YARTEMLEA® (narsoplimab-wuug), which targets the lectin pathway’s effector enzyme MASP-2, is FDA-approved and commercially available in the U.S. for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in adult and pediatric patients aged two years and older.. OMS1029, Omeros’ long-acting MASP-2 inhibitor, has successfully completed Phase 1 clinical trials.
Under a recently announced asset purchase and licensing agreement, Novo Nordisk acquired global rights to zaltenibart (formerly OMS906), an inhibitor of MASP-3, the alternative pathway’s key activator, which is in clinical development for PNH and other alternative pathway indications, along with associated intellectual property and related assets. Omeros’ pipeline also includes OMS527, a phosphodiesterase 7 inhibitor in clinical development for cocaine use disorder, which is fully funded by the National Institute on Drug Abuse, and a growing portfolio of novel recombinant antibodies targeting multidrug-resistant organisms and novel molecular and cellular therapeutic programs for oncology. For more information about Omeros and its programs, visit www.omeros.com.
Omeros is proud to offer a competitive total compensation package designed to support the lives of our employees and their families. The wage scale for Sr Manager Patient Services & Advocacy position is ($190,000 - $220,000). Salaries will be determined based on knowledge, skills, education, and experience relevant to the role. Employees are offered medical, dental, vision, life insurance, and a 401(k) plan with a company match. Employees accrue three weeks of vacation and 80 hours of sick time on an annual basis and receive twelve paid holidays throughout the calendar year. This position is eligible for incentive and stock options. To learn more about Omeros, please visit www.omeros.com.
Omeros is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to status as a protected veteran or a qualified individual with a disability, or other protected status such as race, religion, color, national origin, sex, age, marital status, or any other factor determined to be unlawful by federal, state, or local statutes.
It is our policy to provide reasonable accommodation to anyone with a disability who needs assistance completing the job application process. If you need assistance, you can send an e-mail to hr@omeros.com .